Dr Lal Pathlabs Q1 Results: Net profit jumps 44% to 84 crore, revenue up 8% YoY; declares dividend of 6 per share
Dr Lal Pathlabs' consolidated revenue in Q1FY24 increased 7.6% to 541 crore from 502.7 crore, YoY.27-07-2023
27-07-2023
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation with regard to Un-Audited Financial Results for the quarter ended June 30, 202327-07-2023
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on Un-Audited Financial Results for Quarter ended June 30, 202327-07-2023
Dr. Lal PathLabs Ltd - 539524 - Intimation Of Record Date For Payment Of Interim Dividend For FY 2023-24
Intimation of Record Date for Payment of Interim Dividend for FY 2023-2427-07-2023
Dr. Lal PathLabs Ltd - 539524 - Intimation Of Record Date For Payment Of Final Dividend For FY 2022-23
Intimation of Record date for payment of Final Dividend for FY 2022-2327-07-2023
Dr. Lal PathLabs Ltd - 539524 - Granting Of Stock Options
Board of Directors in their meeting held on July 27, 2023 approved granting of ESOPs to eligible employees27-07-2023
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Change in Directorate
Board of Directors in their meeting held on July 27, 2023, approved appointment of Mr. Gurinder Singh Kalra and Mr. Rajit Mehta as Independent Directors27-07-2023
Dr. Lal PathLabs Ltd - 539524 - Corporate Action-Board approves Dividend
Board of Directors in their meeting on July 27, 2023 approved payment of Interim Dividend INR 6/- per equity shares for FY 2023-2427-07-2023
Dr. Lal PathLabs Ltd - 539524 - Board Meeting Outcome for Board Meeting Outcome Of Board Meeting Held On July 27, 2023
Board Meeting Outcome of Board Meeting Held on July 27, 202327-07-2023
Dr. Lal PathLabs Ltd - 539524 - Un-Audited Financial Results For The Quarter Ended June 30, 2023
Un-Audited Financial Results for the quarter ended June 30, 202327-07-2023